Convelo Therapeutics, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Convelo Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2022).
SEC Form D · Dec 2022
The industry group it chose in its notices: Other Health Care.
SEC Form D · Dec 2022
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Convelo Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Derrick Rossi | Executive officer | Dec 2017 |
| Steven Landau | Executive officer | Dec 2017 |
| Bill Sanford | Director | Dec 2022 |
| Derrick Rossi | Director | Dec 2022 |
| Drew Adams | Director | Dec 2022 |
| Paul Tesar | Director | Dec 2022 |
| Ronald Richard | Director | Dec 2022 |